| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MARIZYME, INC. | 10%+ Owner | Common stock | 13.3M | $1.33M | $0.10 | Dec 21, 2023 | BWL Investments Ltd |
| PMGC Holdings Inc. | Director, 10%+ Owner | Series B Preferred Stock | 3.34M | Mar 26, 2025 | By Northstrive Companies Inc. | ||
| MARIZYME, INC. | 10%+ Owner | 10% Secured Convertible Promissory Note | $0 | Dec 21, 2023 | BWL Investments Ltd |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ELAB | PMGC Holdings Inc. | Mar 26, 2025 | 1 | $0 | 4 | Mar 28, 2025 | Director, 10%+ Owner |
| QLGN | Qualigen Therapeutics, Inc. | Oct 8, 2024 | 0 | $0 | 3 | Oct 17, 2024 | Director |
| ELAB | Elevai Labs Inc. | Dec 28, 2023 | 0 | $0 | 3/A | Feb 16, 2024 | 10%+ Owner |
| ELAB | Elevai Labs Inc. | Dec 28, 2023 | 0 | $0 | 3 | Feb 1, 2024 | 10%+ Owner |
| MRZM | MARIZYME, INC. | Dec 21, 2023 | 2 | -$382K | 4 | Dec 28, 2023 | 10%+ Owner |
| MRZM | MARIZYME, INC. | Jun 26, 2023 | 3 | -$36.6K | 4/A | Sep 8, 2023 | 10%+ Owner |